R&D Systems™ Recombinant Human VEGF 145 (aa 27-171) Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Description

The Recombinant Human VEGF 145 (aa 27-171) Protein is derived from E. coli. The Recombinant Human VEGF 145 (aa 27-171) Protein has been validated for the following applications: Bioactivity.